Loading...
Price History
Market Data
| Market Cap | 25.08B |
| P/E Ratio | - |
| P/B Ratio | 81.92 |
| EPS | - |
| Dividend Yield | - |
| D/E Ratio | 4.22 |
| Current Ratio | 1.08 |
| Currency | USD |
Key Financial Metrics
5.89B
Revenue
-308.25M
Net Income
-
EPS (Diluted)
-192.35M
Free Cash Flow
Profitability
Gross Margin
-31.0%
Operating Margin
-6.4%
Net Profit Margin
-5.2%
EBITDA
-328.32M
Returns & Efficiency
Return on Assets (ROA)
-19.3%
Return on Equity (ROE)
-100.7%
Dividend Yield
-
EPS
-
Financial Health
Total Assets
1.60B
Total Debt
-
Debt to Equity
4.22x
Current Ratio
1.08
Insider Trading
Last 12 months
0
Buys
0
Sells
0
Insiders
Quick Access Filings
10-K
Annual Report
Loading...
10-Q
Quarterly Report
Loading...
8-K
Recent News
Loading...
Company Data Library
Earnings Transcripts
Loading...
Press Releases
Loading...
Filing Sections
Loading...
Company Info
| Industry | Health Services |
| HQ | WESTERVILLE, OH |
| Fiscal Year | 2024 |
Peers
DAVITA INC
DVA
12.54B
P/E: --
12.54B
P/E: --
DAVITA INC.
DVA
12.54B
P/E: --
SOTERA HEALTH CO
SHC
4.48B
P/E: 92.5
2.01B
P/E: 142.9
PROGYNY, INC.
PGNY
1.47B
P/E: 40.7
860.49M
P/E: --
349.63M
P/E: 25.0
Quick Links
Financial Statistics
Valuation
Market Cap$25.08B
P/E Ratio (TTM)-
Price to Book81.92
EV/Revenue-
EV/EBITDA-
Profitability
Gross Margin-31.0%
Operating Margin-6.4%
Net Margin-5.2%
ROE-100.7%
ROA-19.3%
Leverage & Liquidity
Debt to Equity4.22
Current Ratio1.08
Total Debt-
Total Assets$1.60B
Stockholders' Equity$306.08M
Income Statement (FY 2024)
Revenue$5.89B
Gross Profit$-1.83B
Operating Income$-377.51M
Net Income$-308.25M
EPS (Diluted)-
Cash Flow (FY 2024)
Free Cash Flow$-192.35M
Cash & Equivalents$171.68M
Revenue Growth-2.9%
SEC Filings by Category
Insider Trading Activity
Neutral
0 Buys $0
0 Sales $0
0 Exercises $0
Net: $0
| Insider | Title | Date | Type | Shares | Price | Value |
|---|
Company Information
| Business Address | 440 POLARIS PARKWAY SUITE 550 WESTERVILLE, OH 43082 |
| Phone | 562-256-3800 |
| Incorporated | DE, US |
| EIN | 371915147 |
| Fiscal Year End | 1231 |
| Shares Outstanding | 414.46M |
| Stockholders' Equity | $306.08M |
| Cash & Equivalents | $171.68M |
Recent Filings
View All
10-Q
Quarterly Report
Quarterly financial report with unaudited statements
Filed: 2026-05-06
Local
8-K
Current Report
Report of material events (acquisitions, earnings, executive changes)
Filed: 2026-05-06
Local
DEFA14A
Additional Proxy Materials
Additional definitive proxy soliciting materials
Filed: 2026-04-27
Local
8-K
Current Report
Report of material events (acquisitions, earnings, executive changes)
Filed: 2026-04-27
Local
ARS
Annual Report to Shareholders
Annual report furnished to shareholders
Filed: 2026-04-23
Local
DEFA14A
Additional Proxy Materials
Additional definitive proxy soliciting materials
Filed: 2026-04-23
Local
DEF 14A
Definitive Proxy Statement
Official proxy statement for shareholder voting
Filed: 2026-04-22
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-04-16
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-04-16
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-04-16
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-04-16
Local
8-K
Current Report
Report of material events (acquisitions, earnings, executive changes)
Filed: 2026-03-30
Local
8-K
Current Report
Report of material events (acquisitions, earnings, executive changes)
Filed: 2026-03-18
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-03-11
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-03-11
Local
Loading...
Loading management data...
Loading...
Loading board of directors...
Loading...
Loading institutional holders...
Loading...
Loading short interest data...
Financial Charts Annual (10-K)
Interactive financial visualizations
Show:
Revenue & Income Trends
Revenue & Profit
Profit Margins
Balance Sheet Breakdown
Assets Composition
Capital Structure
Cash Flow Analysis
Cash Flow Components
Free Cash Flow
Growth & Performance
Revenue Growth Rate (YoY %)
Key Ratio Trends
Company Profile
General Information
| Company Name | AGILON HEALTH, INC. |
| Ticker | AGL |
| Exchange | -- |
| Sector | Services |
| Industry | Health Services |
| Headquarters | WESTERVILLE, OH |
| Fiscal Year | 2024 |
Financial Summary
| Market Cap | 25.08B |
| Revenue | 5.89B |
| Net Income | -308.25M |
| P/E Ratio | - |
| EPS | - |
| Net Margin | -5.2% |
| ROE | -100.7% |
| Dividend Yield | - |
Insider Transactions
Loading...
My Notes & Files
Personal Notes
Attached Files
Loading...